AMGEN INC
AMGEN INC
Action · US0311621009 · AMGN · 867900 (XNAS)
Aperçu Indicateurs financiers
291,50 USD
0,30 % 0,86 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 21:41

Cours actuels de AMGEN INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
AMGN
USD
06.06.2025 21:41
291,50 USD
287,10 USD
+1,53 %
XETR: XETRA
XETRA
AMG.DE
EUR
06.06.2025 15:35
255,15 EUR
254,60 EUR
+0,22 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 2,10 % 7,79 % -8,41 % 6,91 % -5,06 % 29,17 %

Profil de l'entreprise pour AMGEN INC Action

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Fonds investis

Les fonds suivants ont investi dans : AMGEN INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
2.953,80
Part (%)
6,93 %
Fonds
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. en millions
11.287,43
Part (%)
4,18 %
Fonds
iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Vol. en millions
5.880,99
Part (%)
1,71 %
Fonds
iShares MSCI USA SRI UCITS ETF USD (Dist)
Vol. en millions
6.933,02
Part (%)
1,71 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. en millions
6.068,54
Part (%)
1,66 %

Données de l'entreprise

Nom AMGEN INC
Société Amgen Inc.
Symbole AMGN
Site web https://www.amgen.com
Marché d'origine XNAS NASDAQ
WKN 867900
ISIN US0311621009
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Mr. Robert A. Bradway
Capitalisation boursière 130 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 28,0 T
Adresse One Amgen Center Drive, 91320-1799 Thousand Oaks
Date d'introduction en bourse 2000-01-03
Dividendes de 'AMGEN INC'
Date ex-dividende Dividende par action
16.05.2025 2,38 USD
14.02.2025 2,38 USD
18.11.2024 2,25 USD
16.08.2024 2,25 USD
16.05.2024 2,25 USD
15.02.2024 2,25 USD
16.11.2023 2,13 USD
17.08.2023 2,13 USD
17.05.2023 2,13 USD
14.02.2023 2,13 USD

Fractionnements d'actions

Date Fractionnement
22.11.1999 2:1
01.03.1999 2:1
16.08.1995 2:1
11.09.1991 3:1
13.08.1990 2:1

Symboles boursiers

Nom Symbole
Frankfurt AMG.F
NASDAQ AMGN
XETRA AMG.DE

Autres actions

Les investisseurs qui détiennent AMGEN INC ont également les actions suivantes dans leur portefeuille :
3M CO
3M CO Action
ADOBE INC
ADOBE INC Action
AMAZON.CO INC
AMAZON.CO INC Action
APPLE INC
APPLE INC Action
BCO SANTANDER 15/22
BCO SANTANDER 15/22 Obligation
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
CRANE CO.
CRANE CO. Action
INTEL CORP
INTEL CORP Action
JFM 14/21 MTN
JFM 14/21 MTN Obligation
LAKESTAR SPAC I SE
LAKESTAR SPAC I SE Action
MICROSOFT CORP
MICROSOFT CORP Action
NVIDIA CORP
NVIDIA CORP Action
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Action
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025